Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:BDMD NASDAQ:IRIX NASDAQ:LNSR NASDAQ:QTI On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeBDMDBaird Medical Investment$1.64-0.6%$1.87$0.76▼$7.26$67.62M-1.18196,395 shs59,913 shsIRIXIRIDEX$1.01+1.0%$1.10$0.87▼$1.65$17.41M0.6460,845 shs24,667 shsLNSRLENSAR$5.95+1.2%$6.15$5.06▼$14.03$71.17M0.8463,710 shs58,770 shsQTIQT Imaging$5.04-0.4%$6.53$0.72▼$8.50$60.94M0.0172,926 shs54,306 shs(Almost) Everything You Need To Know About The EV MarketLooking to profit from the electric vehicle mega-trend? Click the link to see our list of which EV stocks show the most long-term potential.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceBDMDBaird Medical Investment+0.61%-2.94%-7.82%+6.45%-67.33%IRIXIRIDEX-4.76%-2.91%-4.76%-29.08%-1.96%LNSRLENSAR+1.38%+1.91%+5.95%-48.33%-57.94%QTIQT Imaging-3.44%-19.94%-27.71%-11.86%+432.63%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeBDMDBaird Medical Investment$1.64-0.6%$1.87$0.76▼$7.26$67.62M-1.18196,395 shs59,913 shsIRIXIRIDEX$1.01+1.0%$1.10$0.87▼$1.65$17.41M0.6460,845 shs24,667 shsLNSRLENSAR$5.95+1.2%$6.15$5.06▼$14.03$71.17M0.8463,710 shs58,770 shsQTIQT Imaging$5.04-0.4%$6.53$0.72▼$8.50$60.94M0.0172,926 shs54,306 shs(Almost) Everything You Need To Know About The EV MarketLooking to profit from the electric vehicle mega-trend? Click the link to see our list of which EV stocks show the most long-term potential.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceBDMDBaird Medical Investment+0.61%-2.94%-7.82%+6.45%-67.33%IRIXIRIDEX-4.76%-2.91%-4.76%-29.08%-1.96%LNSRLENSAR+1.38%+1.91%+5.95%-48.33%-57.94%QTIQT Imaging-3.44%-19.94%-27.71%-11.86%+432.63%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceBDMDBaird Medical Investment 1.00SellN/AN/AIRIXIRIDEX 2.00Hold$3.00197.03% UpsideLNSRLENSAR 2.33Hold$10.0068.07% UpsideQTIQT Imaging 2.00HoldN/AN/ACurrent Analyst Ratings BreakdownLatest IRIX, LNSR, BDMD, and QTI Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails5/19/2026IRIXIRIDEX Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeSell (D-) ➝ Sell (E+)5/11/2026LNSRLENSAR Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeSell (D-) ➝ Sell (D+)5/8/2026BDMDBaird Medical Investment Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeSell (D) ➝ Sell (D-)5/4/2026IRIXIRIDEX Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeSell (E+) ➝ Sell (D-)4/24/2026BDMDBaird Medical Investment Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (D)4/21/2026LNSRLENSAR Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (D-)4/20/2026QTIQT Imaging Zacks ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeStrong Sell ➝ Hold4/1/2026LNSRLENSAR Lake Street CapitalSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeHold ➝ Buy$10.003/17/2026LNSRLENSAR BTIG ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeNeutral ➝ Buy$10.002/27/2026QTIQT Imaging Zacks ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeHold ➝ Strong Sell(Data available from 5/21/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookBDMDBaird Medical Investment$22.54M2.98N/AN/AN/A∞IRIXIRIDEX$52.67M0.33N/AN/A($0.07) per share-14.43LNSRLENSAR$58.44M1.23N/AN/A$0.89 per share6.69QTIQT Imaging$18.92M3.21N/AN/A$0.32 per share15.75Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateBDMDBaird Medical InvestmentN/AN/AN/AN/AN/AN/AN/AN/AN/AIRIXIRIDEX-$4.44M-$0.26N/AN/AN/A-6.23%-1,204.74%-11.16%8/6/2026 (Estimated)LNSRLENSAR-$34.28M-$0.58N/AN/AN/A50.94%-183.19%42.26%8/6/2026 (Estimated)QTIQT Imaging-$21.08M-$1.24N/A19.38N/A-58.93%-4,220.38%-51.77%8/6/2026 (Estimated)Latest IRIX, LNSR, BDMD, and QTI EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/19/2026Q1 2026IRIXIRIDEX-$0.07-$0.03+$0.04-$0.03$11.91 million$11.80 million5/13/2026Q1 2026QTIQT Imaging-$0.1350-$0.25-$0.1150-$0.25$6.45 million$6.53 million5/8/2026Q1 2026LNSRLENSAR$0.1850$1.56+$1.3750N/A$13.40 million$13.43 million3/31/2026Q4 2025LNSRLENSAR-$0.10-$0.12-$0.02-$0.12$20.30 million$16.03 million3/26/2026Q4 2025IRIXIRIDEX-$0.02-$0.01+$0.01-$0.01$14.74 million$14.72 millionCompare DividendsCompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive GrowthBDMDBaird Medical InvestmentN/AN/AN/AN/AN/AIRIXIRIDEXN/AN/AN/AN/AN/ALNSRLENSARN/AN/AN/AN/AN/AQTIQT ImagingN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioBDMDBaird Medical InvestmentN/AN/AN/AIRIXIRIDEXN/A1.921.32LNSRLENSARN/A2.381.08QTIQT Imaging1.382.491.69Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipBDMDBaird Medical Investment19.78%IRIXIRIDEX20.10%LNSRLENSAR40.15%QTIQT Imaging24.19%Insider OwnershipCompanyInsider OwnershipBDMDBaird Medical Investment78.90%IRIXIRIDEX8.60%LNSRLENSAR66.00%QTIQT Imaging28.80%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableBDMDBaird Medical InvestmentN/A40.98 million8.65 millionN/AIRIXIRIDEX12017.41 million15.90 millionOptionableLNSRLENSAR11012.10 million4.12 millionOptionableQTIQT ImagingN/A12.04 million8.57 millionN/AIRIX, LNSR, BDMD, and QTI HeadlinesRecent News About These CompaniesQT Imaging Holdings Announces Closing of $10 Million Underwritten Public OfferingMay 18 at 4:15 PM | businesswire.comQT Imaging Holdings Announces Pricing of $10 Million Underwritten Public OfferingMay 16, 2026 | finance.yahoo.comQT Imaging (NASDAQ:QTI) Stock Rating Upgraded by Wall Street ZenMay 16, 2026 | americanbankingnews.comQT Imaging Holdings, Inc.May 14, 2026 | edition.cnn.comQT Imaging Holdings Inc (QTI) Q1 2026 Earnings Call Highlights: Strong Revenue Growth Amid ...May 14, 2026 | finance.yahoo.comQT Imaging Q1 Earnings Call HighlightsMay 13, 2026 | marketbeat.comQT Imaging Holdings, Inc. (QTI) Q1 2026 Earnings Call TranscriptMay 13, 2026 | seekingalpha.comQT Imaging Holdings Q1 2026 Earnings Call: Complete TranscriptMay 13, 2026 | finance.yahoo.comQT Imaging Reports First Quarter 2026 Revenue of $6.5 MillionMay 13, 2026 | businesswire.comQT Imaging to Hold First Quarter 2026 Conference Call on May 13, 2026May 6, 2026 | finance.yahoo.comQT Imaging (QTI) Projected to Post Quarterly Earnings on TuesdayMay 5, 2026 | marketbeat.comQT Imaging (NASDAQ:QTI) Stock Rating Upgraded by Zacks ResearchApril 22, 2026 | marketbeat.comQT Imaging Debuts the QT Imaging-Olea Viewer for Integrated, Multimodality Breast Imaging Within a Single User InterfaceApril 15, 2026 | businesswire.comQT Imaging Holdings Insider Trading Activity | NASDAQ:QTI | BenzingaApril 8, 2026 | benzinga.comQT Imaging Holdings, Inc. Common Stock (QTI)April 4, 2026 | nasdaq.comQT Imaging CEO Discusses the Importance of Early Breast Cancer Detection at the Shiftmakers’ Panel and GalaApril 2, 2026 | gazettextra.comGQT Imaging CEO Discusses the Importance of Early Breast Cancer Detection at the Shiftmakers' Panel and GalaApril 2, 2026 | businesswire.comQT Imaging Releases Its Next Generation Breast Imaging Reconstruction SoftwareApril 1, 2026 | businesswire.comQT Imaging Holdings Inc (QTI) Q4 2025 Earnings Call Highlights: Record Revenue Growth and ...March 26, 2026 | uk.finance.yahoo.comQT Imaging Reports 2025 Fourth Quarter and Full Year Financial ResultsMarch 25, 2026 | finance.yahoo.comQT Imaging Receives UAE Regulatory ClearanceMarch 24, 2026 | businesswire.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeIRIX, LNSR, BDMD, and QTI Company DescriptionsBaird Medical Investment NASDAQ:BDMD$1.64 -0.01 (-0.61%) Closing price 04:00 PM EasternExtended Trading$1.63 -0.01 (-0.61%) As of 06:29 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Baird Medical Investment Holdings Ltd. is a medical technology company, which engages in the development and provision of medical devices. It is also involved in the design, development, manufacturing, and sale of microwave ablation medical devices, as well as sale of other medical devices. The company was founded on June 16, 2023 and is headquartered in Guangzhou, China.IRIDEX NASDAQ:IRIX$1.01 +0.01 (+1.00%) Closing price 04:00 PM EasternExtended Trading$1.03 +0.02 (+1.98%) As of 07:55 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.IRIDEX Corporation, an ophthalmic medical technology company, provides therapeutic based laser systems, delivery devices, and consumable instrumentation to treat sight-threatening eye diseases in ophthalmology. It offers laser consoles, such as Cyclo G6 laser system for use in the treatment of glaucoma; IQ 532 and IQ 577 laser systems, which are used for the treatment of retinal disorders; and OcuLight TX, OcuLight SL, OcuLight SLx, OcuLight GL, and OcuLight GLx laser photocoagulation systems that are used to treat proliferative diabetic retinopathy, macular holes, retinal tears, and detachments. The company also provides delivery devices, including TxCell scanning laser delivery system that allows the physician to perform multi-spot pattern scanning; slit lamp adapter, which allows the physician to utilize a standard slit lamp in diagnosis and treatment procedures; and laser indirect ophthalmoscope for use in procedures to treat peripheral retinal disorders. It offers MicroPulse P3 Probe, which is used with its Cylco G6 laser system to perform MicroPulse transscleral laser therapy; G-Probe, which is used in procedures to treat uncontrolled glaucoma; G-Probe and G-Probe Illuminate, which are used in procedures to treat refractory glaucoma; and EndoProbe family of products for use in vitrectomy procedures. The company serves ophthalmologists, research and teaching hospitals, government installations, surgical centers, hospitals, veterinary practices, and office clinics. It markets its products through direct and independent sales force in the United States, as well as through independent distributors internationally. The company was formerly known as IRIS Medical Instruments, Inc. and changed its name to IRIDEX Corporation in November 1995. IRIDEX Corporation was incorporated in 1989 and is headquartered in Mountain View, California.LENSAR NASDAQ:LNSR$5.95 +0.07 (+1.19%) Closing price 04:00 PM EasternExtended Trading$5.65 -0.30 (-5.03%) As of 07:58 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.LENSAR, Inc., a commercial-stage medical device company, focuses on designing, developing, and marketing a femtosecond laser system for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism. It offers LENSAR Laser System that incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes, efficiency, and reproducibility by providing imaging, procedure planning, design, and precision. The company also offers ALLY Adaptive Cataract Treatment System, a platform design to femtosecond laser technology features that enhanced laser capabilities into a single small unit that allows surgeons to perform a femtosecond laser assisted cataract procedure in a single operating room. LENSAR, Inc. was incorporated in 2004 and is headquartered in Orlando, Florida.QT Imaging NASDAQ:QTI$5.04 -0.02 (-0.40%) Closing price 04:00 PM EasternExtended Trading$5.04 0.00 (0.00%) As of 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.QT Imaging Holdings, Inc. engages in the research, development, and commercialization of body imaging systems for detection, diagnosis, monitoring, and treatment of diseases. The company offers QT Ultrasound Breast Scanner, an ultrasonic imaging system that provides reflection-mode and transmission-mode images of a patient's breast. QT Imaging Holdings, Inc. was founded in 2011 and is based in Novato, California. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSilverSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas NVIDIA Price Pullback? Don’t Count on It, Business Is Accelerating Meta Platforms 10% Layoff Raises a Bigger Question About AI Spending Target Shows Strengths, But Analysts Want to See More Freight Boom: The Hormuz Blockade Payday TJX Companies Fires on All Cylinders With 9% Revenue Growth Analog Devices Provides Much-Needed Pullback: How Low Can It Go? USA Rare Earth Posts Strong Q1 2026 as Massive Serra Vera Deal Looms From Zepbound to Foundayo: Lilly's Latest Results Support Oral GLP-1 Outlook Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
